Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both ...

JavaScript’s low bar to entry has resulted in one of the richest programming language ecosystems in the world. This month’s report celebrates the bounty, while also highlighting a recent example of ...

On July 22, 2025, Replimune revealed that the FDA had issued a Complete Response Letter (CRL) for its Biologics License Application for RP1, a novel immunotherapy aimed at treating advanced melanoma.

WRITE well designed, testable, efficient code by using best Software Development practices as the next Software Engineer sought to join the team of a dynamic Digital Transformation Specialist. You ...

It’s a typical scenario. You’re faced with a lingering problem, like an argument with a friend, a looming deadline, or a difficult decision. You think you should try to tackle it, but all you really ...

When it comes to casting, arguably no role in the world garners more attention than that of James Bond. Connery, Brosnan, Craig, each of us has our favourite version of the iconic British spy. Now, ...

The never not-lovable Bob Odenkirk resumes kicking major tuckus in Nobody 2 (now streaming on VOD platforms like Amazon Prime Video), the sequel to 2021’s highly entertaining average-guy-goes-HAM ...

NEW YORK - September 3, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks ...

Claudio Bozzi does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

When “Chicago Med” Season 10 wrapped in May, it ended with a huge question: Who is the father of Hannah’s (Jessy Schram) baby? While it appeared she was on her way to tell her ex, Dr. Ripley (Luke ...